We are live on ! Find out more

Large Cap Healthcare
Stocks Ranked by
Market Capitalization

Name Market cap Price Price
change %
IDXX icon
26
Idexx Laboratories
IDXX
$44.9B
$44.9B $569.77 0%
HUM icon
27
Humana
HUM
$43.9B
$43.9B $365.41 0%
IQV icon
28
IQVIA
IQV
$40.7B
$40.7B $247.56 0%
TEVA icon
29
Teva Pharmaceuticals
TEVA
$40.4B
$40.4B $34.71 0%
A icon
30
Agilent Technologies
A
$39.6B
$39.6B $140.30 0%
RVMD icon
31
Revolution Medicines
RVMD
$38.5B
$38.5B $180.92 0%
ALNY icon
32
Alnylam Pharmaceuticals
ALNY
$38.3B
$38.3B $286.62 0%
WAT icon
33
Waters Corp
WAT
$37.3B
$37.3B $379.48 0%
NTRA icon
34
Natera
NTRA
$36.4B
$36.4B $253.82 0%
ALC icon
35
Alcon
ALC
$34B
$34B $69.65 0%
ONC
36
BeOne Medicines Ltd
ONC
$33.9B
$33.9B $327.21 0%
MDLN
37
Medline Inc
MDLN
$33.9B
$33.9B $40.08 0%
VEEV icon
38
Veeva Systems
VEEV
$33.8B
$33.8B $207.91 0%
ZTS icon
39
Zoetis
ZTS
$32.7B
$32.7B $77.93 0%
GEHC icon
40
GE HealthCare
GEHC
$32.5B
$32.5B $71.90 0%
RMD icon
41
ResMed
RMD
$31.1B
$31.1B $214.29 0%
BIIB icon
42
Biogen
BIIB
$30.9B
$30.9B $209.23 0%
CNC icon
43
Centene
CNC
$30.5B
$30.5B $61.82 0%
ILMN icon
44
Illumina
ILMN
$29.5B
$29.5B $194.82 0%
DXCM icon
45
DexCom
DXCM
$29B
$29B $75.14 0%
MTD icon
46
Mettler-Toledo International
MTD
$28.1B
$28.1B $1,388.33 0%
RPRX icon
47
Royalty Pharma
RPRX
$26.2B
$26.2B $59.18 0%
UTHR icon
48
United Therapeutics
UTHR
$26.1B
$26.1B $524.70 0%
DGX icon
49
Quest Diagnostics
DGX
$26B
$26B $235.22 0%
INCY icon
50
Incyte
INCY
$25.8B
$25.8B $127.10 0%
1
2
3 4

Large Cap Healthcare Stocks at a Glance

Healthcare companies develop drugs, build medical devices, run hospitals and insurers, and supply the systems behind patient care. Demand is largely non-discretionary, but returns hinge on drug-pipeline outcomes, patent lives, and reimbursement policy — a mix of defensive services and high-risk, high-reward research bets.

There are 98 large cap Healthcare stocks — companies in the Healthcare sector with a market cap between $10B and $200B — worth a combined $4.05T.

The largest by market cap are Abbott (ABT) at $187B, Gilead Sciences (GILD) at $165B and Pfizer (PFE) at $143B.

Among institutional investors, Waters Corp (WAT) drew the most net new fund positions in Q1 2026: 461 funds opened new positions, taking total fund holders up 365 (45%) quarter-over-quarter.

  • Combined market cap: $4.05T across 98 stocks.
  • Large Cap: market cap between $10B and $200B.
  • Largest constituent: Abbott (ABT), $187B market cap.
  • Most net new fund positions in Q1 2026: Waters Corp (WAT), +365 holders.

Market caps and prices updated daily; fund activity based on aggregated SEC 13F filings for Q1 2026.